Výsledky vyhledávání

Akademický článek

Complete esophageal obstruction following endoscopic variceal band ligation

Autor: Abhijit Bhatia, Carlton Sexton, Anita Ahmed, Harjit Chahal

Publikováno v: Journal of Community Hospital Internal Medicine Perspectives, Vol 3, Iss 1, Pp 1-3 (2013)

Variceal hemorrhage is a potential complication of portal hypertension. Besides medical management, endoscopic variceal band ligation (EVBL) has emerged as a promising prophylactic tool proving to be superior to sclerotherapy. EBVL is a simple proced

Externí odkaz: https://doaj.org/article/dd7dd7e561e543b6847445e3fa8834ab

Zobrazit plný text záznamu

Plný text ve formátu HTML

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Results of a phase II, open-label pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma (NEO-Nal-IRI study).

Autor: George, Thomas J., Rogers, Sherise C., Nassour, Ibrahim, Sahin, Ilyas, Ramnaraign, Brian Hemendra, Fabregas, Jesus, Hitchcock, Kathryn, Lin, Tuo, Liu, Gonghao, Zlotecki, Robert, Kayaleh, Omar Roger, Turk, Anita Ahmed, Fan, Z. Hugh, Russell, Karen Bullock, DeRemer, David L., Lee, Ji-Hyun, Hughes, Steven J.

Publikováno v: Journal of Clinical Oncology; 2024 Supplement 3, Vol. 42, p655-655, 117p

Zobrazit plný text záznamu

Phase I study of trifluridine/tipiracil in combination with gemcitabine (gem) and nab-paclitaxel (nab-P) in patients (pts) with advanced pancreatic ductal adenocarcinoma (PDAC)

Autor: Anita Ahmed Turk, Paul R. Helft, Amikar Sehdev, Safi Shahda, Patrick J. Loehrer

Publikováno v: Journal of Clinical Oncology. 41:731-731

731 Background: The incidence of PDAC is on the rise and it is predicted to be the 2nd leading cause of cancer related mortality in the next decade. Most patients present with advanced disease at diagnoses with limited systemic treatment options. Flu

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::fbcfddb638335ada6977e98f2e12666e
https://doi.org/10.1200/jco.2023.41.4_suppl.731

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Acceptance and commitment therapy for fatigue interference in advanced gastrointestinal cancer and caregiver burden: protocol of a pilot randomized controlled trial

Autor: Ahmad Al-Hader, Ekin Secinti, Victoria L. Champion, Paul R. Helft, Shelley A. Johns, Catherine E. Mosher, Patrick J. Loehrer, Anita Ahmed Turk, Kurt Kroenke, Amikar Sehdev

Publikováno v: Pilot and Feasibility Studies
Pilot and Feasibility Studies, Vol 7, Iss 1, Pp 1-12 (2021)

Background Fatigue interference with activities, mood, and cognition is one of the most prevalent and bothersome concerns of advanced gastrointestinal (GI) cancer patients. As fatigue interferes with patient functioning, family caregivers often repor

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a632dcab9d2c7a3fb8b684c820d0cdd8
http://europepmc.org/articles/PMC8056101

Zobrazit plný text záznamu

A phase II, open-label, pilot study evaluating the safety and activity of liposomal irinotecan (Nal-IRI) in combination with 5-FU and oxaliplatin (NALIRIFOX) in preoperative treatment of pancreatic adenocarcinoma: NEO-Nal-IRI study

Autor: Sherise C. Rogers, Brian Hemendra Ramnaraign, Kathryn Hitchcock, Steven J. Hughes, Ji-Hyun Lee, Anita Ahmed Turk, Karen Bullock Russell, Ibrahim Nassour, Ahmad El-Far, Jesus C. Fabregas, Ryan M. Thomas, Ilyas Sahin, Carmen Joseph Allegra, David L. DeRemer, Thomas J. George

Publikováno v: Journal of Clinical Oncology. 40:TPS4196-TPS4196

TPS4196 Background: Neoadjuvant treatment for potentially curable pancreatic cancer (PDAC) is increasing in acceptability, but a standard regimen has yet to be established. Multiple studies have demonstrated feasibility and effectiveness of the FOLFI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4412e3143f5f62b5ab0d803426aeae4f
https://doi.org/10.1200/jco.2022.40.16_suppl.tps4196

Zobrazit plný text záznamu

BTCRC-GI20-457: A phase II study of atezolizumab and bevacizumab in Child-Pugh B7 hepatocellular carcinoma (the AB7 Trial)

Autor: Kristen Renee Spencer, Anita Ahmed Turk, Shikha Jain, Kelsey Klute, Sam Joseph Lubner, Dirk F. Moore, Howard S. Hochster

Publikováno v: Journal of Clinical Oncology. 40:TPS493-TPS493

TPS493 Background: Both the incidence and death rate of hepatocellular carcinoma (HCC) are on the rise in the United States, and overall, the prognosis is grim. First-line treatment options for patients with advanced disease previously included tyros

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::8e9aceb063278713a2398d24b91b0f00
https://doi.org/10.1200/jco.2022.40.4_suppl.tps493

Zobrazit plný text záznamu

PARP inhibitors in breast cancer: Bringing synthetic lethality to the bedside

Autor: Anita Ahmed Turk, Kari B. Wisinski

Publikováno v: Cancer. 124:2498-2506

Individuals with breast and ovarian cancer susceptibility gene 1 (BRCA1) or BRCA2 germline mutations have a significantly increased lifetime risk for breast and ovarian cancers. BRCA-mutant cancer cells have abnormal homologous recombination (HR) rep

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::d86aebb017a6fef84851167811213609
https://doi.org/10.1002/cncr.31307

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání